FDMT. – 4D Molecular Therapeutics Inc
FDMT — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
25.74
Margin Of Safety %
Put/Call OI Ratio
0.47
EPS Next Q Diff
EPS Last/This Y
-1.29
EPS This/Next Y
Price
10.35
Target Price
27.62
Analyst Recom
1.4
Performance Q
13.63
Upside
-434.4%
Beta
2.77
Ticker: FDMT
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-13 | FDMT | 10.03 | 0.46 | 0.00 | 5362 |
| 2026-04-14 | FDMT | 9.65 | 0.46 | 0.00 | 5360 |
| 2026-04-15 | FDMT | 9.77 | 0.45 | 0.33 | 5371 |
| 2026-04-20 | FDMT | 10.07 | 0.06 | 1.60 | 1500 |
| 2026-04-23 | FDMT | 9.62 | 0.47 | 0.22 | 2080 |
| 2026-04-24 | FDMT | 9.41 | 0.47 | 0.06 | 2097 |
| 2026-04-27 | FDMT | 9.46 | 0.47 | 0.50 | 2112 |
| 2026-04-28 | FDMT | 9.41 | 0.47 | 999.99 | 2120 |
| 2026-04-29 | FDMT | 8.82 | 0.47 | 3.75 | 2121 |
| 2026-04-30 | FDMT | 8.88 | 0.48 | 1.00 | 2138 |
| 2026-05-01 | FDMT | 9.1 | 0.48 | 0.00 | 2140 |
| 2026-05-04 | FDMT | 9.43 | 0.47 | 999.99 | 2145 |
| 2026-05-05 | FDMT | 9.73 | 0.48 | 0.50 | 2148 |
| 2026-05-06 | FDMT | 10.41 | 0.48 | 0.00 | 2150 |
| 2026-05-07 | FDMT | 9.95 | 0.48 | 2.00 | 2146 |
| 2026-05-08 | FDMT | 10.15 | 0.48 | 999.99 | 2146 |
| 2026-05-11 | FDMT | 10.81 | 0.48 | 0.00 | 2151 |
| 2026-05-12 | FDMT | 10.36 | 0.47 | 0.22 | 2203 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-13 | FDMT | 10.03 | -15.8 | - | -3.83 |
| 2026-04-14 | FDMT | 9.65 | -15.8 | - | -3.83 |
| 2026-04-15 | FDMT | 9.77 | -15.8 | - | -3.83 |
| 2026-04-16 | FDMT | 10.07 | -15.8 | - | -3.83 |
| 2026-04-17 | FDMT | 10.50 | -15.8 | - | -3.83 |
| 2026-04-20 | FDMT | 10.06 | -15.8 | - | -3.83 |
| 2026-04-21 | FDMT | 9.76 | -15.8 | - | -3.83 |
| 2026-04-22 | FDMT | 9.81 | -15.8 | - | -3.83 |
| 2026-04-23 | FDMT | 9.63 | -15.8 | - | -3.83 |
| 2026-04-24 | FDMT | 9.42 | -15.8 | - | -3.83 |
| 2026-04-27 | FDMT | 9.47 | -15.8 | - | -3.83 |
| 2026-04-28 | FDMT | 9.41 | -15.8 | - | -3.83 |
| 2026-04-30 | FDMT | 8.88 | -15.8 | - | -3.83 |
| 2026-05-01 | FDMT | 9.10 | -15.8 | - | -3.83 |
| 2026-05-04 | FDMT | 9.44 | -15.8 | - | -3.83 |
| 2026-05-05 | FDMT | 9.72 | -15.8 | - | -3.83 |
| 2026-05-06 | FDMT | 10.42 | -15.8 | - | -3.83 |
| 2026-05-07 | FDMT | 9.94 | -15.8 | - | -3.83 |
| 2026-05-08 | FDMT | 10.14 | -15.8 | - | -3.83 |
| 2026-05-11 | FDMT | 10.80 | -15.8 | - | -3.71 |
| 2026-05-12 | FDMT | 10.35 | 4.2 | - | -3.71 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-13 | FDMT | -0.19 | 22.45 | 23.88 |
| 2026-04-14 | FDMT | -0.19 | 22.45 | 23.88 |
| 2026-04-15 | FDMT | -0.15 | 22.45 | 23.88 |
| 2026-04-16 | FDMT | -0.15 | 22.45 | 23.88 |
| 2026-04-17 | FDMT | -0.15 | 22.45 | 23.88 |
| 2026-04-20 | FDMT | -0.15 | 22.31 | 23.88 |
| 2026-04-21 | FDMT | -0.12 | 22.31 | 23.88 |
| 2026-04-22 | FDMT | -0.12 | 22.31 | 23.88 |
| 2026-04-23 | FDMT | -0.12 | 22.31 | 23.87 |
| 2026-04-24 | FDMT | -0.12 | 22.31 | 23.87 |
| 2026-04-27 | FDMT | -0.12 | 22.87 | 25.32 |
| 2026-04-28 | FDMT | -0.07 | 22.87 | 25.32 |
| 2026-04-29 | FDMT | -0.07 | 22.87 | 25.32 |
| 2026-04-30 | FDMT | -0.07 | 22.87 | 25.32 |
| 2026-05-01 | FDMT | -0.07 | 22.87 | 24.72 |
| 2026-05-04 | FDMT | -0.07 | 21.53 | 24.72 |
| 2026-05-05 | FDMT | -0.07 | 21.53 | 24.72 |
| 2026-05-06 | FDMT | -0.07 | 21.53 | 24.72 |
| 2026-05-07 | FDMT | -0.07 | 21.53 | 24.72 |
| 2026-05-08 | FDMT | -0.07 | 21.53 | 24.72 |
| 2026-05-11 | FDMT | -0.07 | 21.16 | 24.72 |
| 2026-05-12 | FDMT | -0.07 | 21.16 | 25.74 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.94
Avg. EPS Est. Next Quarter
-0.92
Insider Transactions
-0.07
Institutional Transactions
21.16
Beta
2.77
Average Sales Estimate Current Quarter
2
Average Sales Estimate Next Quarter
2
Fair Value
Quality Score
22
Growth Score
49
Sentiment Score
95
Actual DrawDown %
71.5
Max Drawdown 5-Year %
-93
Target Price
27.62
P/E
Forward P/E
PEG
P/S
6.13
P/B
1.2
P/Free Cash Flow
EPS
-2.66
Average EPS Est. Cur. Y
-3.71
EPS Next Y. (Est.)
-3.71
Target Price Estimates Raised
Target Price Estimates Lowered
1
Profit Margin
-182.34
Relative Volume
0.61
Return on Equity vs Sector %
-62.5
Return on Equity vs Industry %
-47
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.12
EBIT Estimation
◆
FDMT
Healthcare
$10.34
Swing / Pullback
Buy the dip on strong trends
WATCH
RSI
56.7
Range 1M
67.7%
Sup Dist
0.8%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-60.7%
EPS NY
4.3%
52W%
79%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+167.1% upside
Upside
+167.1%
Quality
22
4D Molecular Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 196
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. The company's lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. It is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in preclinical stage for treating geographic atrophy; and 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Otsuka Pharmaceutical Co., Ltd. The company was founded in 2013 and is headquartered in EmeryVille, California.
FDMT
Latest News
—
Caricamento notizie per FDMT…
stock quote shares FDMT. – 4D Molecular Therapeutics Inc Stock Price stock today
news today FDMT. – 4D Molecular Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FDMT. – 4D Molecular Therapeutics Inc yahoo finance google finance
stock history FDMT. – 4D Molecular Therapeutics Inc invest stock market
stock prices FDMT premarket after hours
ticker FDMT fair value insiders trading